|
AU2003200966B2
|
|
Yeast cells expressing modified G proteins and methods of use therefor
|
|
US2003054402A1
|
|
Methods and compositions for identifying receptor effectors
|
|
AU7169600A
|
|
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
|
AU2030000A
|
|
Methods and compositions for identifying receptor effectors
|
|
US6251605B1
|
|
Yeast cells having mutations in Cav1 and uses therefor
|
|
WO9963099A1
|
|
Functional expression of adenosine receptors in yeast
|
|
WO9958670A1
|
|
Ags proteins and nucleic acid molecules and uses therefor
|
|
US6355473B1
|
|
Yeast cells having mutations in stp22 and uses therefor
|
|
AU3354499A
|
|
Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
|
|
AU3289599A
|
|
Mekk1 proteins and fragments thereof for use in regulating apoptosis
|
|
US2003009022A1
|
|
Methods and compositions for identifying receptor effectors
|
|
CA2305204A1
|
|
Yeast cells expressing modified g proteins and methods of use therefor
|
|
AU8296698A
|
|
(kds) protein kinase molecules and uses related thereto
|
|
WO9854116A1
|
|
Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
|
|
AU7699898A
|
|
Conformationally constrained peptidomimetics as beta-turn templates and modulators of sh3 domains
|
|
WO9845231A1
|
|
Supports for solid phase synthesis
|
|
EP0929691A2
|
|
Methods and compositions for identifying receptor effectors
|
|
AU3055697A
|
|
Functional expression of heterologous adenylyl cyclase
|
|
AU6110896A
|
|
Expression of functional vertebrate phospholipases in yeast
|
|
US6255059B1
|
|
Methods for identifying G protein coupled receptor effectors
|
